GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Ambu AS (OCSE:AMBU B) » Definitions » EV-to-EBIT

Ambu AS (OCSE:AMBU B) EV-to-EBIT : 56.63 (As of Jun. 01, 2025)


View and export this data going back to 1993. Start your Free Trial

What is Ambu AS EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Ambu AS's Enterprise Value is kr26,899 Mil. Ambu AS's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 was kr475 Mil. Therefore, Ambu AS's EV-to-EBIT for today is 56.63.

The historical rank and industry rank for Ambu AS's EV-to-EBIT or its related term are showing as below:

OCSE:AMBU B' s EV-to-EBIT Range Over the Past 10 Years
Min: 33.67   Med: 78.27   Max: 905.72
Current: 56.63

During the past 13 years, the highest EV-to-EBIT of Ambu AS was 905.72. The lowest was 33.67. And the median was 78.27.

OCSE:AMBU B's EV-to-EBIT is ranked worse than
85.19% of 459 companies
in the Medical Devices & Instruments industry
Industry Median: 19.21 vs OCSE:AMBU B: 56.63

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Ambu AS's Enterprise Value for the quarter that ended in Mar. 2025 was kr31,335 Mil. Ambu AS's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 was kr475 Mil. Ambu AS's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2025 was 1.52%.


Ambu AS EV-to-EBIT Historical Data

The historical data trend for Ambu AS's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ambu AS EV-to-EBIT Chart

Ambu AS Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 131.34 146.49 131.44 74.16 106.67

Ambu AS Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 59.42 59.13 106.67 62.20 65.97

Competitive Comparison of Ambu AS's EV-to-EBIT

For the Medical Devices subindustry, Ambu AS's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ambu AS's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Ambu AS's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Ambu AS's EV-to-EBIT falls into.


;
;

Ambu AS EV-to-EBIT Calculation

Ambu AS's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=26899.287/475
=56.63

Ambu AS's current Enterprise Value is kr26,899 Mil.
Ambu AS's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was kr475 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ambu AS  (OCSE:AMBU B) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Ambu AS's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2025 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2025 ) =EBIT / Enterprise Value (Q: Mar. 2025 )
=475/31334.7005
=1.52 %

Ambu AS's Enterprise Value for the quarter that ended in Mar. 2025 was kr31,335 Mil.
Ambu AS's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was kr475 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ambu AS EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Ambu AS's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Ambu AS Business Description

Traded in Other Exchanges
Address
Baltorpbakken 13, Ballerup, DNK, DK-2750
Ambu AS is a Denmark based company providing single-use flexible endoscopes and is dedicated to optimizing hospital workflows and improving patient care. The company has created medtech solutions like resuscitators, anaesthesia masks, and electrodes and operates R&D, manufacturing and sales in Europe, North America and Rest of the world.

Ambu AS Headlines

No Headlines